Engineering CAR T Cells: Advances in Vector Design and Gene Editing
- 2 January 2026
- book chapter
- Published by Springer Nature
- p. 61-95
Abstract
No abstract availableKeywords
This publication has 149 references indexed in Scilit:
- The design of retroviral vectors used in the CAR‐T products, risk management, and future perspectiveMedcomm, 2025
- mRNA‐based chimeric antigen receptor T cell therapy: Basic principles, recent advances and future directionsInterdisciplinary Medicine, 2023
- CAR γδ T cells for cancer immunotherapy. Is the field more yellow than green?Cancer Immunology, Immunotherapy, 2022
- CAR-NK Cells from Engineered Pluripotent Stem Cells: Off-the-shelf Therapeutics for all PatientsStem Cells Translational Medicine, 2021
- Hematopoietic Stem Cell- and Induced Pluripotent Stem Cell-Derived CAR-NK Cells as Reliable Cell-Based Therapy SolutionsStem Cells Translational Medicine, 2021
- Economic Evaluation of Chimeric Antigen Receptor T-Cell Therapy by Site of Care Among Patients With Relapsed or Refractory Large B-Cell LymphomaJAMA Network Open, 2020
- Antibody‐Based CAR T Cells Produced by Lentiviral TransductionCurrent Protocols in Immunology, 2020
- Production of Lentivirus for the Establishment of CAR-T Cells2019
- CARs of the futureAmerican Journal of Hematology, 2019
- Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerationsClinical & Translational Immunology, 2019